Delivery Order 266995360-00266200209C0000266995360

This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract, valued at $2,900,275.00, is for AIDS research (basic) work and does not have a set-aside designation. Southern Research Institute, doing business as Southern Research, has a history of providing drug discovery, development, and...

This is a definitive cost no fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the J. David Gladstone Institutes, a non-profit biomedical research organization located in San Francisco, California. The contract, valued at $7,323,791, is for AIDS research (basic) with a period of performance through November 30, 2006. The contract does not have a set-aside designation. The J. David Gladstone...

This is a $12,436,225.00 Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to BBI Biotech Research Laboratories Incorporated on June 30, 1998 for AIDS research (basic). The contract has an ultimate completion date of December 31, 2007 and was not set aside for any special designation. As NIAID is the research arm of the National Institutes of Health focused on infectious diseases, this contract is likely...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a nonprofit research organization. The contract is for the "Identification of Lead Compounds to Inhibit HIV-1 Regulatory Proteins" and has a ceiling value of $516,565. This is a cost-plus-fixed-fee delivery order contract, without a set-aside designation. Southern Research Institute holds...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...

This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) for R&D and medical support services related to AIDS research. The contract has a ceiling value of $2,857,610.47 and a period of performance through August 29, 2024. This award is not associated with a set-aside program. ABL, a foreign-owned, for-profit...

This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Diadexus, Inc., a for-profit manufacturer, for AIDS research activities. The contract has a potential value of $80,286,861.00 and a completion date of April 3, 2007. The contract was awarded on September 30, 2003 and does not have a set-aside designation. The place of...

Advanced Bioscience Laboratories, Inc., doing business as Advanced Bioscience Laboratories Inc., has been awarded an $893,336 cost-plus-fixed-fee delivery order against the HIV Microbicides and Biomedical Prevention 2016-2021 master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this award, the contractor will provide expertise in the development and optimization of antiretroviral therapy for...

This federal contract, awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases, tasks Southern Research Institute with testing interventional agents in confirmatory and specialized assays to identify and characterize agents with activity to block HIV infection, inhibit HIV gene expression and replication, or cure infected cells of HIV infection. The contract, which has a potential value of $174,999.00, does not have a set-aside designation and was...